علاج الحمامى العقدية الثانوية عندما لا يُحقق البريدنيزون الفموي أو الكورتيكوستيرويدات داخل الآفة تراجع العقيدات

References

DOI: 10.1007/s40257-021-00592-w

Tumor necrosis factor-α inhibitors such as etanercept, adalimumab, and infliximab have been used in patients with recalcitrant disease.

Erythema nodosum is generally self-limited and resolves within 1–6 weeks by turning from a bright red to a yellow–brown or green-bluish discoloration, resembling bruises.